The global market for Sunitinib API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sunitinib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sunitinib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sunitinib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sunitinib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sunitinib API players cover Hunan Huateng Pharmaceutical, Hangzhou Longshine Bio-Tech, Sichuan Xieli Pharmaceutical, Gonane Pharma and NEWEDGE Overseas, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sunitinib API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sunitinib API market, with both quantitative and qualitative data, to help readers understand how the Sunitinib API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Sunitinib API market and forecasts the market size by Purity (0.98, 0.99 and 0.999), by Application (Capsules and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.98
0.99
0.999
Others
Segmentation by application
Capsules
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hunan Huateng Pharmaceutical
Hangzhou Longshine Bio-Tech
Sichuan Xieli Pharmaceutical
Gonane Pharma
NEWEDGE Overseas
Teva API
Acebright India Pharma
Biotechnica Pharma
Bulat Pharmaceutical
Danesh Kimia Pharmed
Hikma Pharmaceuticals
MSN Laboratories
Mylan Inc
Vannsh Life Sciences
Chapter Introduction
Chapter 1: Scope of Sunitinib API, Research Methodology, etc.
Chapter 2: Executive Summary, global Sunitinib API market size (sales and revenue) and CAGR, Sunitinib API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sunitinib API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sunitinib API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sunitinib API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hunan Huateng Pharmaceutical, Hangzhou Longshine Bio-Tech, Sichuan Xieli Pharmaceutical, Gonane Pharma, NEWEDGE Overseas, Teva API, Acebright India Pharma, Biotechnica Pharma and Bulat Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sunitinib API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sunitinib API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sunitinib API by Country/Region, 2017, 2022 & 2028
2.2 Sunitinib API Segment by Purity
2.2.1 0.98
2.2.2 0.99
2.2.3 0.999
2.2.4 Others
2.3 Sunitinib API Sales by Purity
2.3.1 Global Sunitinib API Sales Market Share by Purity (2017-2022)
2.3.2 Global Sunitinib API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Sunitinib API Sale Price by Purity (2017-2022)
2.4 Sunitinib API Segment by Application
2.4.1 Capsules
2.4.2 Others
2.5 Sunitinib API Sales by Application
2.5.1 Global Sunitinib API Sale Market Share by Application (2017-2022)
2.5.2 Global Sunitinib API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sunitinib API Sale Price by Application (2017-2022)
3 Global Sunitinib API by Company
3.1 Global Sunitinib API Breakdown Data by Company
3.1.1 Global Sunitinib API Annual Sales by Company (2020-2022)
3.1.2 Global Sunitinib API Sales Market Share by Company (2020-2022)
3.2 Global Sunitinib API Annual Revenue by Company (2020-2022)
3.2.1 Global Sunitinib API Revenue by Company (2020-2022)
3.2.2 Global Sunitinib API Revenue Market Share by Company (2020-2022)
3.3 Global Sunitinib API Sale Price by Company
3.4 Key Manufacturers Sunitinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sunitinib API Product Location Distribution
3.4.2 Players Sunitinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sunitinib API by Geographic Region
4.1 World Historic Sunitinib API Market Size by Geographic Region (2017-2022)
4.1.1 Global Sunitinib API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sunitinib API Annual Revenue by Geographic Region
4.2 World Historic Sunitinib API Market Size by Country/Region (2017-2022)
4.2.1 Global Sunitinib API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sunitinib API Annual Revenue by Country/Region
4.3 Americas Sunitinib API Sales Growth
4.4 APAC Sunitinib API Sales Growth
4.5 Europe Sunitinib API Sales Growth
4.6 Middle East & Africa Sunitinib API Sales Growth
5 Americas
5.1 Americas Sunitinib API Sales by Country
5.1.1 Americas Sunitinib API Sales by Country (2017-2022)
5.1.2 Americas Sunitinib API Revenue by Country (2017-2022)
5.2 Americas Sunitinib API Sales by Purity
5.3 Americas Sunitinib API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sunitinib API Sales by Region
6.1.1 APAC Sunitinib API Sales by Region (2017-2022)
6.1.2 APAC Sunitinib API Revenue by Region (2017-2022)
6.2 APAC Sunitinib API Sales by Purity
6.3 APAC Sunitinib API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sunitinib API by Country
7.1.1 Europe Sunitinib API Sales by Country (2017-2022)
7.1.2 Europe Sunitinib API Revenue by Country (2017-2022)
7.2 Europe Sunitinib API Sales by Purity
7.3 Europe Sunitinib API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sunitinib API by Country
8.1.1 Middle East & Africa Sunitinib API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sunitinib API Revenue by Country (2017-2022)
8.2 Middle East & Africa Sunitinib API Sales by Purity
8.3 Middle East & Africa Sunitinib API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sunitinib API
10.3 Manufacturing Process Analysis of Sunitinib API
10.4 Industry Chain Structure of Sunitinib API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sunitinib API Distributors
11.3 Sunitinib API Customer
12 World Forecast Review for Sunitinib API by Geographic Region
12.1 Global Sunitinib API Market Size Forecast by Region
12.1.1 Global Sunitinib API Forecast by Region (2023-2028)
12.1.2 Global Sunitinib API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sunitinib API Forecast by Purity
12.7 Global Sunitinib API Forecast by Application
13 Key Players Analysis
13.1 Hunan Huateng Pharmaceutical
13.1.1 Hunan Huateng Pharmaceutical Company Information
13.1.2 Hunan Huateng Pharmaceutical Sunitinib API Product Offered
13.1.3 Hunan Huateng Pharmaceutical Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hunan Huateng Pharmaceutical Main Business Overview
13.1.5 Hunan Huateng Pharmaceutical Latest Developments
13.2 Hangzhou Longshine Bio-Tech
13.2.1 Hangzhou Longshine Bio-Tech Company Information
13.2.2 Hangzhou Longshine Bio-Tech Sunitinib API Product Offered
13.2.3 Hangzhou Longshine Bio-Tech Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.2.5 Hangzhou Longshine Bio-Tech Latest Developments
13.3 Sichuan Xieli Pharmaceutical
13.3.1 Sichuan Xieli Pharmaceutical Company Information
13.3.2 Sichuan Xieli Pharmaceutical Sunitinib API Product Offered
13.3.3 Sichuan Xieli Pharmaceutical Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sichuan Xieli Pharmaceutical Main Business Overview
13.3.5 Sichuan Xieli Pharmaceutical Latest Developments
13.4 Gonane Pharma
13.4.1 Gonane Pharma Company Information
13.4.2 Gonane Pharma Sunitinib API Product Offered
13.4.3 Gonane Pharma Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Gonane Pharma Main Business Overview
13.4.5 Gonane Pharma Latest Developments
13.5 NEWEDGE Overseas
13.5.1 NEWEDGE Overseas Company Information
13.5.2 NEWEDGE Overseas Sunitinib API Product Offered
13.5.3 NEWEDGE Overseas Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 NEWEDGE Overseas Main Business Overview
13.5.5 NEWEDGE Overseas Latest Developments
13.6 Teva API
13.6.1 Teva API Company Information
13.6.2 Teva API Sunitinib API Product Offered
13.6.3 Teva API Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva API Main Business Overview
13.6.5 Teva API Latest Developments
13.7 Acebright India Pharma
13.7.1 Acebright India Pharma Company Information
13.7.2 Acebright India Pharma Sunitinib API Product Offered
13.7.3 Acebright India Pharma Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Acebright India Pharma Main Business Overview
13.7.5 Acebright India Pharma Latest Developments
13.8 Biotechnica Pharma
13.8.1 Biotechnica Pharma Company Information
13.8.2 Biotechnica Pharma Sunitinib API Product Offered
13.8.3 Biotechnica Pharma Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biotechnica Pharma Main Business Overview
13.8.5 Biotechnica Pharma Latest Developments
13.9 Bulat Pharmaceutical
13.9.1 Bulat Pharmaceutical Company Information
13.9.2 Bulat Pharmaceutical Sunitinib API Product Offered
13.9.3 Bulat Pharmaceutical Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bulat Pharmaceutical Main Business Overview
13.9.5 Bulat Pharmaceutical Latest Developments
13.10 Danesh Kimia Pharmed
13.10.1 Danesh Kimia Pharmed Company Information
13.10.2 Danesh Kimia Pharmed Sunitinib API Product Offered
13.10.3 Danesh Kimia Pharmed Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Danesh Kimia Pharmed Main Business Overview
13.10.5 Danesh Kimia Pharmed Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Sunitinib API Product Offered
13.11.3 Hikma Pharmaceuticals Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 MSN Laboratories
13.12.1 MSN Laboratories Company Information
13.12.2 MSN Laboratories Sunitinib API Product Offered
13.12.3 MSN Laboratories Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 MSN Laboratories Main Business Overview
13.12.5 MSN Laboratories Latest Developments
13.13 Mylan Inc
13.13.1 Mylan Inc Company Information
13.13.2 Mylan Inc Sunitinib API Product Offered
13.13.3 Mylan Inc Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Mylan Inc Main Business Overview
13.13.5 Mylan Inc Latest Developments
13.14 Vannsh Life Sciences
13.14.1 Vannsh Life Sciences Company Information
13.14.2 Vannsh Life Sciences Sunitinib API Product Offered
13.14.3 Vannsh Life Sciences Sunitinib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Vannsh Life Sciences Main Business Overview
13.14.5 Vannsh Life Sciences Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Sunitinib API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sunitinib API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.98
Table 4. Major Players of 0.99
Table 5. Major Players of 0.999
Table 6. Major Players of Others
Table 7. Global Sunitinib API Sales by Purity (2017-2022) & (Tons)
Table 8. Global Sunitinib API Sales Market Share by Purity (2017-2022)
Table 9. Global Sunitinib API Revenue by Purity (2017-2022) & ($ million)
Table 10. Global Sunitinib API Revenue Market Share by Purity (2017-2022)
Table 11. Global Sunitinib API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 12. Global Sunitinib API Sales by Application (2017-2022) & (Tons)
Table 13. Global Sunitinib API Sales Market Share by Application (2017-2022)
Table 14. Global Sunitinib API Revenue by Application (2017-2022)
Table 15. Global Sunitinib API Revenue Market Share by Application (2017-2022)
Table 16. Global Sunitinib API Sale Price by Application (2017-2022) & (US$/Kg)
Table 17. Global Sunitinib API Sales by Company (2020-2022) & (Tons)
Table 18. Global Sunitinib API Sales Market Share by Company (2020-2022)
Table 19. Global Sunitinib API Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sunitinib API Revenue Market Share by Company (2020-2022)
Table 21. Global Sunitinib API Sale Price by Company (2020-2022) & (US$/Kg)
Table 22. Key Manufacturers Sunitinib API Producing Area Distribution and Sales Area
Table 23. Players Sunitinib API Products Offered
Table 24. Sunitinib API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sunitinib API Sales by Geographic Region (2017-2022) & (Tons)
Table 28. Global Sunitinib API Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sunitinib API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sunitinib API Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sunitinib API Sales by Country/Region (2017-2022) & (Tons)
Table 32. Global Sunitinib API Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sunitinib API Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sunitinib API Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sunitinib API Sales by Country (2017-2022) & (Tons)
Table 36. Americas Sunitinib API Sales Market Share by Country (2017-2022)
Table 37. Americas Sunitinib API Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sunitinib API Revenue Market Share by Country (2017-2022)
Table 39. Americas Sunitinib API Sales by Type (2017-2022) & (Tons)
Table 40. Americas Sunitinib API Sales Market Share by Purity (2017-2022)
Table 41. Americas Sunitinib API Sales by Application (2017-2022) & (Tons)
Table 42. Americas Sunitinib API Sales Market Share by Application (2017-2022)
Table 43. APAC Sunitinib API Sales by Region (2017-2022) & (Tons)
Table 44. APAC Sunitinib API Sales Market Share by Region (2017-2022)
Table 45. APAC Sunitinib API Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sunitinib API Revenue Market Share by Region (2017-2022)
Table 47. APAC Sunitinib API Sales by Purity (2017-2022) & (Tons)
Table 48. APAC Sunitinib API Sales Market Share by Purity (2017-2022)
Table 49. APAC Sunitinib API Sales by Application (2017-2022) & (Tons)
Table 50. APAC Sunitinib API Sales Market Share by Application (2017-2022)
Table 51. Europe Sunitinib API Sales by Country (2017-2022) & (Tons)
Table 52. Europe Sunitinib API Sales Market Share by Country (2017-2022)
Table 53. Europe Sunitinib API Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sunitinib API Revenue Market Share by Country (2017-2022)
Table 55. Europe Sunitinib API Sales by Type (2017-2022) & (Tons)
Table 56. Europe Sunitinib API Sales Market Share by Purity (2017-2022)
Table 57. Europe Sunitinib API Sales by Application (2017-2022) & (Tons)
Table 58. Europe Sunitinib API Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sunitinib API Sales by Country (2017-2022) & (Tons)
Table 60. Middle East & Africa Sunitinib API Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sunitinib API Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sunitinib API Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sunitinib API Sales by Purity (2017-2022) & (Tons)
Table 64. Middle East & Africa Sunitinib API Sales Market Share by Purity (2017-2022)
Table 65. Middle East & Africa Sunitinib API Sales by Application (2017-2022) & (Tons)
Table 66. Middle East & Africa Sunitinib API Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sunitinib API
Table 68. Key Market Challenges & Risks of Sunitinib API
Table 69. Key Industry Trends of Sunitinib API
Table 70. Sunitinib API Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sunitinib API Distributors List
Table 73. Sunitinib API Customer List
Table 74. Global Sunitinib API Sales Forecast by Region (2023-2028) & (Tons)
Table 75. Global Sunitinib API Sales Market Forecast by Region
Table 76. Global Sunitinib API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sunitinib API Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sunitinib API Sales Forecast by Country (2023-2028) & (Tons)
Table 79. Americas Sunitinib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sunitinib API Sales Forecast by Region (2023-2028) & (Tons)
Table 81. APAC Sunitinib API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sunitinib API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Europe Sunitinib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sunitinib API Sales Forecast by Country (2023-2028) & (Tons)
Table 85. Middle East & Africa Sunitinib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sunitinib API Sales Forecast by Purity (2023-2028) & (Tons)
Table 87. Global Sunitinib API Sales Market Share Forecast by Purity (2023-2028)
Table 88. Global Sunitinib API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 89. Global Sunitinib API Revenue Market Share Forecast by Purity (2023-2028)
Table 90. Global Sunitinib API Sales Forecast by Application (2023-2028) & (Tons)
Table 91. Global Sunitinib API Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sunitinib API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sunitinib API Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hunan Huateng Pharmaceutical Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 95. Hunan Huateng Pharmaceutical Sunitinib API Product Offered
Table 96. Hunan Huateng Pharmaceutical Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 97. Hunan Huateng Pharmaceutical Main Business
Table 98. Hunan Huateng Pharmaceutical Latest Developments
Table 99. Hangzhou Longshine Bio-Tech Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 100. Hangzhou Longshine Bio-Tech Sunitinib API Product Offered
Table 101. Hangzhou Longshine Bio-Tech Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 102. Hangzhou Longshine Bio-Tech Main Business
Table 103. Hangzhou Longshine Bio-Tech Latest Developments
Table 104. Sichuan Xieli Pharmaceutical Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 105. Sichuan Xieli Pharmaceutical Sunitinib API Product Offered
Table 106. Sichuan Xieli Pharmaceutical Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 107. Sichuan Xieli Pharmaceutical Main Business
Table 108. Sichuan Xieli Pharmaceutical Latest Developments
Table 109. Gonane Pharma Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 110. Gonane Pharma Sunitinib API Product Offered
Table 111. Gonane Pharma Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 112. Gonane Pharma Main Business
Table 113. Gonane Pharma Latest Developments
Table 114. NEWEDGE Overseas Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 115. NEWEDGE Overseas Sunitinib API Product Offered
Table 116. NEWEDGE Overseas Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 117. NEWEDGE Overseas Main Business
Table 118. NEWEDGE Overseas Latest Developments
Table 119. Teva API Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva API Sunitinib API Product Offered
Table 121. Teva API Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 122. Teva API Main Business
Table 123. Teva API Latest Developments
Table 124. Acebright India Pharma Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 125. Acebright India Pharma Sunitinib API Product Offered
Table 126. Acebright India Pharma Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 127. Acebright India Pharma Main Business
Table 128. Acebright India Pharma Latest Developments
Table 129. Biotechnica Pharma Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 130. Biotechnica Pharma Sunitinib API Product Offered
Table 131. Biotechnica Pharma Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 132. Biotechnica Pharma Main Business
Table 133. Biotechnica Pharma Latest Developments
Table 134. Bulat Pharmaceutical Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 135. Bulat Pharmaceutical Sunitinib API Product Offered
Table 136. Bulat Pharmaceutical Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 137. Bulat Pharmaceutical Main Business
Table 138. Bulat Pharmaceutical Latest Developments
Table 139. Danesh Kimia Pharmed Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 140. Danesh Kimia Pharmed Sunitinib API Product Offered
Table 141. Danesh Kimia Pharmed Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 142. Danesh Kimia Pharmed Main Business
Table 143. Danesh Kimia Pharmed Latest Developments
Table 144. Hikma Pharmaceuticals Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 145. Hikma Pharmaceuticals Sunitinib API Product Offered
Table 146. Hikma Pharmaceuticals Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 147. Hikma Pharmaceuticals Main Business
Table 148. Hikma Pharmaceuticals Latest Developments
Table 149. MSN Laboratories Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 150. MSN Laboratories Sunitinib API Product Offered
Table 151. MSN Laboratories Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 152. MSN Laboratories Main Business
Table 153. MSN Laboratories Latest Developments
Table 154. Mylan Inc Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 155. Mylan Inc Sunitinib API Product Offered
Table 156. Mylan Inc Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 157. Mylan Inc Main Business
Table 158. Mylan Inc Latest Developments
Table 159. Vannsh Life Sciences Basic Information, Sunitinib API Manufacturing Base, Sales Area and Its Competitors
Table 160. Vannsh Life Sciences Sunitinib API Product Offered
Table 161. Vannsh Life Sciences Sunitinib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 162. Vannsh Life Sciences Main Business
Table 163. Vannsh Life Sciences Latest Developments
List of Figures
Figure 1. Picture of Sunitinib API
Figure 2. Sunitinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sunitinib API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Sunitinib API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sunitinib API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.98
Figure 10. Product Picture of 0.99
Figure 11. Product Picture of 0.999
Figure 12. Product Picture of Others
Figure 13. Global Sunitinib API Sales Market Share by Purity in 2021
Figure 14. Global Sunitinib API Revenue Market Share by Purity (2017-2022)
Figure 15. Sunitinib API Consumed in Capsules
Figure 16. Global Sunitinib API Market: Capsules (2017-2022) & (Tons)
Figure 17. Sunitinib API Consumed in Others
Figure 18. Global Sunitinib API Market: Others (2017-2022) & (Tons)
Figure 19. Global Sunitinib API Sales Market Share by Application (2017-2022)
Figure 20. Global Sunitinib API Revenue Market Share by Application in 2021
Figure 21. Sunitinib API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Sunitinib API Revenue Market Share by Company in 2021
Figure 23. Global Sunitinib API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Sunitinib API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Sunitinib API Sales Market Share by Region (2017-2022)
Figure 26. Global Sunitinib API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Sunitinib API Sales 2017-2022 (Tons)
Figure 28. Americas Sunitinib API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Sunitinib API Sales 2017-2022 (Tons)
Figure 30. APAC Sunitinib API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Sunitinib API Sales 2017-2022 (Tons)
Figure 32. Europe Sunitinib API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Sunitinib API Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Sunitinib API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Sunitinib API Sales Market Share by Country in 2021
Figure 36. Americas Sunitinib API Revenue Market Share by Country in 2021
Figure 37. United States Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Sunitinib API Sales Market Share by Region in 2021
Figure 42. APAC Sunitinib API Revenue Market Share by Regions in 2021
Figure 43. China Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Sunitinib API Sales Market Share by Country in 2021
Figure 50. Europe Sunitinib API Revenue Market Share by Country in 2021
Figure 51. Germany Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Sunitinib API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Sunitinib API Revenue Market Share by Country in 2021
Figure 58. Egypt Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Sunitinib API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Sunitinib API in 2021
Figure 64. Manufacturing Process Analysis of Sunitinib API
Figure 65. Industry Chain Structure of Sunitinib API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles